Constitutive DAMPs in CNS injury: From preclinical insights to clinical perspectives
Brain, Behavior, and Immunity · 2024-11 · 122 · 583-595
DOI: 10.1016/j.bbi.2024.07.047 ↗Kurz gefasst
Übersichtsarbeit in der Zeitschrift Brain, Behavior, and Immunity, 2024-11. Verfasst von Adrian Castellanos-Molina und 4 weiteren Autor:innen. Beteiligte Einrichtung: Axe Neurosciences du Centre de recherche du Centre hospitalier universitaire (CHU) de Québec-Université Laval et Département de médecine moléculaire …. Hauptthemen laut MEDLINE: Alarmins, Central Nervous System. Die Arbeit wurde bisher 40-mal zitiert (Crossref) und nennt 147 Literaturangaben. Der Volltext ist frei zugänglich (Open Access, CC BY 4.0). Gefördert von: Wings for Life Spinal International, Canadian Institutes of Health Research.
Abstract (Originalsprache)
Damage-associated molecular patterns (DAMPs) are endogenous molecules released in tissues upon cellular damage and necrosis, acting to initiate sterile inflammation. Constitutive DAMPs (cDAMPs) have the particularity to be present within the intracellular compartments of healthy cells, where they exert diverse functions such as regulation of gene expression and cellular homeostasis. However, after injury to the central nervous system (CNS), cDAMPs are rapidly released by stressed, damaged or dying neuronal, glial and endothelial cells, and can trigger inflammation without undergoing structural modifications. Several cDAMPs have been described in the injured CNS, such as interleukin (IL)-1α, IL-33, nucleotides (e.g. ATP), and high-mobility group box protein 1. Once in the extracellular milieu, these molecules are recognized by the remaining surviving cells through specific DAMP-sensing receptors, thereby inducing a cascade of molecular events leading to the production and release of proinflammatory cytokines and chemokines, as well as cell adhesion molecules. The ensuing immune response is necessary to eliminate cellular debris caused by the injury, allowing for damage containment. However, seeing as some molecules associated with the inflammatory response are toxic to surviving resident CNS cells, secondary damage occurs, aggravating injury and exacerbating neurological and behavioral deficits. Thus, a better understanding of these cDAMPs, as well as their receptors and downstream signaling pathways, could lead to identification of novel therapeutic targets for treating CNS injuries such as SCI, TBI, and stroke. In this review, we summarize the recent literature on cDAMPs, their specific functions, and the therapeutic potential of interfering with cDAMPs or their signaling pathways.
Schlagwörter
MeSH-Schlagwörter (MEDLINE)
Stichwörter der Autor:innen
Substanzen
Autor:innen und Institutionen
- Axe Neurosciences du Centre de recherche du Centre hospitalier universitaire (CHU) de Québec-Université Laval et Département de médecine moléculaire de l'Université Laval, Québec, QC G1V 4G2, Canada.
- Axe Neurosciences du Centre de recherche du Centre hospitalier universitaire (CHU) de Québec-Université Laval et Département de médecine moléculaire de l'Université Laval, Québec, QC G1V 4G2, Canada. Electronic address:…
Förderung
- Wings for Life Spinal International
- Canadian Institutes of Health Research
Zitieren
APA
Castellanos-Molina, A., Bretheau, F., Boisvert, A., Bélanger, D., & Lacroix, S. (2024). Constitutive DAMPs in CNS injury: From preclinical insights to clinical perspectives. Brain, Behavior, and Immunity, 122, 583-595. https://doi.org/10.1016/j.bbi.2024.07.047
Vancouver
Castellanos-Molina A, Bretheau F, Boisvert A, Bélanger D, Lacroix S. Constitutive DAMPs in CNS injury: From preclinical insights to clinical perspectives. Brain, Behavior, and Immunity. 2024;122:583-595. doi:10.1016/j.bbi.2024.07.047
BibTeX
@article{CastellanosMolina2024,
author = {Castellanos-Molina, Adrian and Bretheau, Floriane and Boisvert, Ana and Bélanger, Dominic and Lacroix, Steve},
title = {Constitutive DAMPs in CNS injury: From preclinical insights to clinical perspectives},
journal = {Brain, Behavior, and Immunity},
year = {2024},
volume = {122},
pages = {583--595},
doi = {10.1016/j.bbi.2024.07.047}
}
EUVIMED